Ritlecitinib: First Approval

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Ritlecitinib: First Approval ; volume:83 ; number:14 ; day:9 ; month:8 ; year:2023 ; pages:1315-1321 ; date:9.2023
Drugs ; 83, Heft 14 (9.8.2023), 1315-1321, 9.2023

Creator
Blair, Hannah A.
Contributor
SpringerLink (Online service)

DOI
10.1007/s40265-023-01928-y
URN
urn:nbn:de:101:1-2024010210194432229479
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Blair, Hannah A.
  • SpringerLink (Online service)

Other Objects (12)

Sparsentan: First Approval

Sparsentan: First Approval

Eplontersen: First Approval

Eplontersen: First Approval

Zilucoplan: First Approval

Zilucoplan: First Approval

Zavegepant: First Approval

Zavegepant: First Approval

Spesolimab: First Approval

Spesolimab: First Approval

Lonafarnib: First Approval

Lonafarnib: First Approval

Nedosiran: First Approval

Nedosiran: First Approval

Tralokinumab: First Approval

Tralokinumab: First Approval

Efgartigimod: First Approval

Efgartigimod: First Approval

Daridorexant: First Approval

Daridorexant: First Approval

Fuzuloparib: First Approval

Fuzuloparib: First Approval

Pexidartinib: First Approval

Pexidartinib: First Approval

Related objects